onsit
multiplex
biosensor
innat
immun
antibodi
ideal
tool
monitor
health
statu
individu
variou
diseas
studi
introduc
novel
antibodi
immunoassay
test
platform
incorpor
microfiberbas
array
antigen
captur
specif
antibodi
fabric
setup
devic
revolv
around
electrospun
polystyren
esp
microfib
act
threedimension
membran
filter
capabl
rapid
multifold
analyt
captur
particular
esp
microfib
pattern
local
oxygen
plasma
creat
hydrophil
zone
facilit
fluid
flow
immobil
antigen
bulk
robust
antibodi
immunoassay
platform
could
instal
compact
syringedriven
cassett
devic
could
perform
multiplex
antibodi
immunoassay
antibodi
specif
middl
east
respiratori
syndrom
coronaviru
merscov
rapid
prepar
amount
total
min
well
high
sensit
specif
merscov
clinic
use
immunoassay
platform
expect
highthroughput
rapid
highli
sensit
basic
requir
necessari
perform
thu
assay
combin
characterist
propos
often
realiz
use
microfluid
nanotechnolog
furthermor
mani
type
multiplex
immunoassay
platform
report
includ
microelectromechan
system
mem
paperbas
beadbas
arraybas
platform
recent
year
one
promin
applic
immunoassay
platform
perspect
healthcar
viru
detect
sinc
merscov
becom
preval
issu
affect
multipl
countri
coronaviru
affect
individu
high
mortal
rate
report
world
health
organ
furthermor
merscov
rel
recent
outbreak
effect
vaccin
clinic
approv
treat
individu
therefor
mean
antibodi
diagnost
simpl
robust
rapid
manner
necessari
test
vaccin
drug
efficaci
upon
patient
also
prevent
spread
infecti
diseas
world
vaccin
blood
antibodi
titr
often
form
enzymelink
immunosorb
assay
elisa
common
method
determin
whether
patient
current
necessari
antibodi
adequ
concentr
elisa
highli
sensit
method
achiev
limit
detect
lod
merscov
test
take
day
produc
diagnost
result
due
requir
specialist
larg
equip
thu
rapid
effect
test
methodolog
requir
larg
test
apparatu
desir
test
vaccin
drug
efficaci
particular
import
emphas
need
lowcost
simpl
robust
pointofcar
poc
devic
manufactur
order
improv
global
healthcar
rapid
immunoassay
methodolog
antivir
antibodi
test
conduct
within
minut
introduc
work
illustr
construct
novel
multiplex
antibodi
immunoassay
test
leverag
esp
microfib
mat
captur
membran
pressuredriven
convect
ultrarapid
test
addit
previous
establish
fluorescentlylink
immunosorb
assay
flisa
microfib
platform
microfib
mat
prepattern
plasma
creat
multipl
hydrophil
zone
differ
antigen
thu
creat
multiplex
detect
system
proof
concept
two
differ
antigen
design
individu
captur
correspond
antibodi
test
human
http
receiv
august
receiv
revis
form
octob
accept
octob
serum
albumin
hsa
merscov
hsa
repres
protein
exist
human
plasma
sampl
mer
viral
agent
current
lack
mean
vaccin
simplist
design
eas
fabric
setup
rapid
speed
diagnost
perform
antibodi
detect
system
integr
step
forward
creat
low
cost
commerci
devic
protect
gener
public
health
case
mer
outbreak
polymer
electrospin
process
pellet
ps
ps
japan
dissolv
solut
contain
thf
sigmaaldrich
dmf
sigmaaldrich
hsa
full
rapid
flisa
oper
includ
goat
antihuman
albumin
bethyl
laboratori
human
refer
serum
bethyl
laboratori
fitcconjug
goat
antihuman
albumin
bethyl
laboratori
note
antihsa
hsa
fitc
antihsa
studi
respect
antibodi
test
hsa
reagent
mention
follow
mer
reagent
hismersnp
antigen
protein
yokohama
citi
univers
antimersnp
mab
yokohama
citi
univers
util
note
studi
mer
fitc
antim
reagent
respect
antimersnp
label
fluorescein
label
kit
nh
dojindo
inc
phosphat
buffer
salin
pb
ph
gibco
tween
pbst
ph
wv
tween
skim
milk
yukijirushi
inc
util
differ
purpos
like
diluent
wash
block
agent
addit
fitcconjug
bovin
serum
albumin
bsafitc
sigmaaldrich
bsa
sigma
aldrich
util
combin
esp
fiber
mat
fluoresc
microscopi
prepellet
ps
vol
vol
dissolv
solut
thfdmf
solut
left
stir
mildli
room
temperatur
h
allow
ps
dissolv
entir
ps
solut
load
syring
electrospin
devic
environment
process
condit
set
note
supplementari
materi
tabl
electrospin
wetpress
techniqu
report
wu
et
al
appli
microfib
techniqu
layer
esp
fiber
mat
stack
layer
fiber
atop
one
anoth
soak
ethanol
etoh
sandwich
stack
glass
sheet
press
kg
weight
h
use
plasma
cleaner
expand
plasma
cleaner
harrick
plasma
pair
ga
flowmet
pdffmg
plasmaflo
ga
flow
mixer
harrick
plasma
util
treat
esp
fiber
mat
plasma
steel
mask
hole
spot
size
mm
custommad
creat
pattern
plasma
treatment
esp
fiber
mat
esp
wt
fiber
mat
wetpress
util
spot
treatment
experiment
wt
esp
use
rather
sampl
sinc
sampl
show
spread
ad
reagent
nonhydrophil
spot
region
time
sampl
show
minim
spread
leak
reagent
beyond
scope
plasma
treat
hydrophil
spot
esp
fiber
mat
spot
treatment
test
protein
adsorpt
block
prefer
fluoresc
microscopi
protein
adsorpt
esp
fiber
mat
submerg
fitcbsa
solut
wt
fitcbsa
bsa
ml
pb
h
sampl
dipwash
pbst
time
block
effect
test
compar
bsa
blockingon
skim
milk
block
agent
three
separ
esp
fiber
mat
soak
respect
block
solut
bsa
wv
blockingon
vv
skim
milk
wv
h
dip
wash
pbst
time
sampl
soak
fitcbsa
solut
previou
experi
h
dipwash
pbst
time
fluoresc
imag
measur
invert
microscop
olympu
pair
fluoresc
light
sourc
filter
uhglgp
olympu
imag
taken
cellsen
olympu
imag
process
softwar
measur
imagej
nation
institut
health
roi
manag
tool
monitor
advantec
adapt
cassett
devic
replac
intern
membran
wt
esp
sampl
togeth
appropri
cut
shape
filter
paper
mm
kiriyama
rohto
layer
insid
monitor
hous
environ
setup
lower
layer
filter
paper
upper
layer
plasmtreat
esp
fiber
mat
inlet
bulk
reagent
pb
wash
antigen
secondari
antibodi
insert
flush
opposit
end
outlet
syring
pressur
immunoassay
wt
esp
membran
treat
plasma
treatment
min
util
rapid
immunoassay
test
use
cassett
platform
perform
follow
step
antigen
immobil
block
antibodi
captur
first
hsa
mer
concentr
optim
independ
treat
esp
membran
hsa
concentr
pb
vari
rang
use
per
spot
block
ml
skim
milk
wv
appli
syring
directli
cassett
solut
held
min
pull
outlet
final
ml
fitcconjug
antihsa
antibodi
solut
held
cassett
min
also
flush
similarli
mer
test
first
immobil
hismersnp
concentr
rang
skim
milk
block
procedur
ml
fitcconjug
antim
np
solut
held
cassett
min
flush
hsa
mer
test
wash
conduct
pbst
ml
volum
flush
three
time
cassett
block
step
fitcconjug
antibodi
step
multiplex
immunoassay
conduct
ident
immunoassay
protocol
differ
antigen
pattern
separ
singl
esp
membran
spot
treat
mer
spot
treat
hsa
spot
antigen
immobil
block
perform
ml
skim
milk
wv
held
min
cassett
flush
final
three
differ
test
solut
antibodi
prepar
test
multiplex
esp
membran
ml
fitcconjug
antihsa
solut
dilut
ml
fitcconjug
antim
np
solut
dilut
ml
mixtur
fitcconjug
antihsa
dilut
fitc
conjugatedantim
np
dilut
concentr
antibodi
ident
case
fig
supplementari
materi
tabl
illustr
overal
procedur
well
final
concentr
use
test
protocol
critic
much
antigen
immobil
surfac
enhanc
signal
immunoassay
system
antivir
antibodi
therefor
amount
protein
immobil
optim
microfib
surfac
hydrophob
wt
esp
fiber
mat
sampl
treat
plasma
spot
treatment
differ
time
length
test
protein
adsorpt
surfac
determin
optimum
condit
largest
antibodi
immobil
surfac
bsa
use
model
protein
first
contact
angl
measur
confirm
effect
plasma
treatment
fig
overal
confirm
hydrophil
area
treat
plasma
show
decreas
trend
contact
angl
increas
treatment
time
hand
contact
angl
hydrophob
zone
significantli
alter
among
sampl
next
actual
amount
bsa
adsorpt
plasmatr
sampl
analyz
estim
antigen
immobil
capac
result
vari
plasma
treatment
condit
shown
fig
sampl
treat
min
seen
amount
bsa
adsorb
sampl
lack
suffici
plasma
time
min
like
allow
oxygen
fulli
penetr
fiber
thu
yield
adequatelyhydrophil
fiber
surfac
bsa
solut
penetr
fiber
come
contact
fiber
surfac
hand
excess
sampl
treat
sampl
becom
super
hydrophil
prevent
hydrophob
bond
surfac
protein
sampl
thu
subsequ
experi
min
chosen
optim
time
plasma
treatment
protein
immobil
fiber
surfac
addit
block
agent
optim
esp
sampl
thu
similar
protein
adsorpt
test
conduct
three
type
block
agent
bsa
blockingon
skim
milk
fig
although
display
effici
block
fluoresc
label
bsa
adsorpt
demonstr
skim
milk
perform
best
therefor
subsequ
experi
skim
milk
use
block
agent
provid
proof
concept
studi
clinic
applic
whether
fabric
esp
platform
togeth
design
rapid
immunoassay
protocol
within
devicebas
environ
could
appli
rapid
mer
immunoassay
antibodi
hsa
control
merscov
target
test
use
platform
mention
introduct
attain
rapid
detect
desir
analyt
case
antibodi
examin
immun
system
progress
step
forward
made
toward
prevent
diagnost
first
optim
protocol
antigen
immobil
esp
platform
perform
hsa
mer
antigen
test
separ
optim
hsa
adsorpt
indic
rapidli
increas
trend
increas
amount
hsa
immobil
surfac
plateau
effect
detect
intens
fig
meanwhil
mer
adsorpt
test
demonstr
detect
limit
concentr
less
thu
concentr
valu
use
subsequ
studi
lastli
multiplex
rapid
immunoassay
use
hsa
mer
antigen
perform
fig
three
separ
esp
platform
plasma
treat
spot
process
condit
differ
antibodi
solut
fitcconjug
antihsa
antibodi
fitcconjug
antim
antibodi
mix
fitc
conjug
antihsa
fitcconjug
antim
antibodi
success
observ
upon
esp
platform
test
fitcconjug
antim
antibodi
antihsa
antibodi
solut
mer
hsa
antibodi
could
select
detect
addit
mix
solut
fitcconjug
antim
antihsa
antibodi
ad
antibodi
could
simultan
detect
multiplex
setup
also
note
signal
antibodi
slightli
decreas
mixtur
test
comparison
individu
test
possibl
due
crowd
multiplex
microfiberbas
immunoassay
platform
hing
sever
key
factor
includ
pattern
plasma
treatment
effici
block
warrant
discuss
first
rational
behind
protein
immobil
antibodiesantigen
preferenti
adsorb
hydrophil
spot
great
import
gener
protein
adsorpt
flat
surfac
affect
hydrophob
surfac
potenti
case
epsp
fiber
mat
natur
hydrophob
aris
cassiebaxt
regim
consist
two
kind
hydrophob
materi
untreat
ps
air
plasma
treatment
modifi
surfac
properti
ps
render
hydrophil
flat
ps
plate
surfac
wettabl
water
chang
treatment
plasma
min
interestingli
stark
contrast
flat
plate
plasmatr
ps
microfib
result
greater
level
hydrophil
plasma
treatment
illustr
fig
hydrophil
natur
esp
microfib
mat
plasma
treatment
explain
wenzel
regim
describ
reduc
appar
water
contact
angl
rough
surfac
inde
pattern
plasma
treatment
esp
microfib
mat
result
separ
region
two
differ
regim
hydrophil
surfac
promot
solut
flow
plasmatr
spot
word
plasma
treatment
ps
suitabl
prevent
air
pocket
within
microfib
thu
protein
solut
could
contact
fiber
surfac
wet
contrari
unexpos
hydrophob
surfac
esp
allow
wet
protein
solut
could
contact
fiber
surfac
region
thu
although
total
amount
protein
adsorpt
regul
true
contact
angl
materi
appar
contact
angl
aris
porou
structur
esp
microfib
also
crucial
paramet
dictat
protein
adsorpt
next
brief
discuss
skim
milk
block
agent
import
often
time
immunoassay
conduct
block
agent
commonli
protein
adher
well
surfac
without
prevent
adsorpt
protein
surfac
among
common
choic
skim
milk
bsa
bsabas
product
blockingon
exist
note
fig
skim
milk
best
result
block
case
plasmatr
sampl
mix
varieti
protein
exist
within
skim
milk
could
benefici
penetr
fiber
thu
block
surfac
effect
found
casein
within
milk
effect
block
agent
due
small
protein
size
togeth
protein
within
skim
milk
close
pack
surfac
protein
effect
prevent
nonspecif
adsorpt
surfac
contrast
bsa
rel
larg
molecular
weight
compon
make
random
close
pack
block
surfac
difficult
comparison
skim
milk
anoth
interest
point
skim
milk
consid
amphipath
hydrophil
hydrophob
part
treatment
introduc
surfac
hydrophil
natur
may
allow
milk
effect
bound
surfac
lastli
comparison
multiplex
microfib
platform
use
studi
convent
assay
devic
import
compar
work
studi
conduct
sato
et
al
combinatori
assay
conduct
util
microfluid
chip
togeth
integr
polystyren
bead
measur
iga
antibodi
concentr
similar
microfib
util
studi
increas
surfac
volum
ratio
microbead
pack
microfluid
devic
fill
factor
bead
diamet
although
abl
achiev
high
level
sensit
straightforward
stepbystep
immunoassay
procedur
antigen
immobil
captur
colloid
gold
labelediga
antibodi
took
roughli
h
compar
sever
minut
studi
thu
sensit
speed
often
fine
balanc
immunoassay
prioriti
chosen
base
applic
assay
multiplex
microfib
platform
studi
intend
antibodi
detect
poc
monitor
antibodi
level
recent
report
antibodi
titer
patient
infect
merscov
rang
depend
time
post
infect
neutral
antibodi
titer
consid
elisa
often
use
determin
antibodi
titer
lod
around
suggest
requir
antibodi
concentr
neutral
merscov
would
thu
lod
antimerscov
antibodi
multiplex
microfib
platform
although
yet
low
establish
platform
would
suffici
detect
necessari
antibodi
product
mersinfect
patient
multiplex
esp
fiber
system
hous
suit
poc
introduc
mean
rapid
mer
antibodi
detect
capabl
rapid
flisa
exhibit
util
esp
fiber
mat
treat
plasma
pattern
plasma
treatment
method
develop
mask
show
optim
protein
adsorpt
result
min
turn
creat
hydrophil
surfac
capabl
antibodi
immobil
rapid
flisa
test
term
detect
surfac
effect
detect
could
achiev
upon
platform
within
min
oper
time
furthermor
actual
setup
prepar
devic
could
complet
min
includ
captur
molecul
immobil
block
wash
step
result
demonstr
capabl
devic
multiplex
analysi
detect
antibodi
hsa
merscov
concurr
microfiberbas
multiplex
immunoassay
platform
serv
step
stone
nextgener
poc
devic
would
enabl
prevent
diagnost
accur
rapidli
determin
exist
adequ
antibodi
aid
gener
healthcar
appropri
vaccin
scheme
